New Bern, NCCIK 19406464 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
86 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Royal Bk Cda | 65.6K | $11.18M | 2.4% | −1.3K | Reduced |
| 2 | Banco Bilbao Vizcaya Argenta | 454.6K | $10.60M | 2.2% | −66.7K | Reduced |
| 3 | Astrazeneca PLC | 115.1K | $10.58M | 2.2% | −4.5K | Reduced |
| 4 | Novartis AG |
| 74.9K |
| $10.33M |
| 2.2% |
| +494 |
| Added |
| 5 | Bnp Paribas | 215.9K | $10.23M | 2.2% | +35.5K | Added |
| 6 | Toyota Motor Corp | 47.8K | $10.23M | 2.2% | +251 | Added |
| 7 | Roche Hldg Ltd Adr | 196.0K | $10.11M | 2.1% | −2.3K | Reduced |
| 8 | Capgemini S E Unsponsored Adr | 300.8K | $10.02M | 2.1% | +4.8K | Added |
| 9 | Ambev SA | 4.02M | $9.94M | 2.1% | −9.0K | Reduced |
| 10 | Totalenergies Se | 150.5K | $9.85M | 2.1% | +150.5K | New |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio